Peter Leitner, VP of Cyclotron Solutions at IBA, on the current state of the often-overlooked, but critically important field of nuclear medicine, from diagnostics to treatment of a huge range of medical conditions including many common cancers such as lymphoma, and the natural evolution of that industry in places like Wallonia in Belgium, where clusters of companies like IBA are leveraging on the country’s long head start as one of the first nations experimenting with nuclear technology in lifesaving applications like radio-pharmaceuticals